According to a recently published report by Roots Analysis, the increased focus by drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure, while operating in accordance with the standard GMP guidelines, is driving market growth
The global modular construction market is anticipated to grow at a CAGR of 9.89% from 2023-2035, reaching USD 7.7 billion by 2035
Modular construction is a process wherein factory-produced, pre-engineered building units, which are constructed offsite under controlled plant conditions, are assembled on site to construct the final structure. It is worth mentioning that such buildings use the same material and are designed according to the same codes and standards established for conventionally built structures. These fundamental building units are called modules. Integrated assemblies are joined together to create facilities of a significant size, housing multiple functions and equipment. In recent years, with the advent of generic copies of billion-dollar blockbuster drugs, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches. The increased demand for multi-product, multi-purpose, smaller batch-size facilities has also prompted equipment manufacturers to revisit their product offerings.
Browse 155+ figures and 180+ market data tables spread across 385+ pages and detailed Table of Content on “Modular Construction Market, by Size of Facility, Type of Industry Served, Type of Modular Construct, Type of Construction Component, Purpose of Facility, Scale of Operation, Type of Product, Type of Facility, Type of Modular Construction, Type of Material Used and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/modular-manufacturing-market/178.html
Various factors contribute to the market growth of modular construction market. Modular construction minimizes waste, energy consumption, and environmental disturbance compared to traditional methods. This aligns with the industry's sustainability goals and regulatory requirements. Further supportive policies, incentives, and funding for sustainable and efficient construction methods are driving the adoption of modular facilities in the pharma and biotech sector. This creates a conducive environment for market growth and innovation. Additionally, increasing global population and urbanization are necessitating rapid and flexible construction solutions. In this regard, modular construction offers the advantage of shorter project timelines, addressing the demand for timely infrastructure development in urban areas.
One of the primary restraints associated with this industry is shortage of construction materials. The industry's dependence on high-quality materials could be jeopardized by shortages or disruptions in the supply chain, thereby affecting the availability and cost of materials for modular construction. Moreover, fluctuations in material costs, transportation expenses, and labor rates have the potential to drive up overall project costs, potentially undermining the cost-effectiveness of modular construction in the pharma and biotech sector. Additionally, a lack of comprehensive understanding of the advantages and technical prerequisites of modular construction among stakeholders, such as designers, regulators, and investors, could hinder its widespread adoption in the industry.
Despite the challenges, several growth factors continue to drive the modular construction market forward. Modular construction offers benefits, such as quality control, accelerated project delivery, and reduced on-site labor, aligning with the industry's need for efficient, compliant, and adaptable facilities. Further, the expansion of the pharma and biotech industry in emerging markets drives the demand for flexible, rapidly deployable infrastructure, making modular construction an attractive solution for meeting evolving production and regulatory needs. The ability of modular construction to minimize project schedules, mitigate cost overruns, and enable concurrent site and off-site work enhances its appeal for pharma and biotech facilities, supporting efficient capacity expansion and technology adoption.
The modular construction market report also includes detailed profiles of key players (listed below) that offer Modular Construction services:
You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/178/request-sample.html
Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner
SUBSCRIBE TO INDUSTRY UPDATES